Evaluation Of Cabozantinib (Cabo) In Combination With Direct Oral Anticoagulants (Doac) Or Low Molecular Weight Heparin (Lmwh) In Renal Cell Carcinoma (Rcc).

Akram Mesleh Shayeb,Danielle Urman,Nazli Dizman,Luis A Meza,Akhilesh Sivakumar,Chun Loo Gan,Hannah Elizabeth Dzimitrowicz,Tian Zhang,Pedro C. Barata,Mehmet Asim Bilen,Xin Gao,Daniel Yick Chin Heng,Sumanta K. Pal,Marina D. Kaymakcalan,Bradley Alexander McGregor,Toni K. Choueiri,Rana R. McKay

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 1|浏览13

暂无评分

摘要

291Background: Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer. Despite cabo improving RCC outcomes, VTE management in these patients remains a challenge, ...

查看译文

关键词

Low molecular weight heparin,Cabozantinib,Cause of death,Renal cell carcinoma,Cancer,Oncology,Medicine,In patient,Internal medicine,Venous thromboembolism

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要